Arcadia Biosciences (RKDA) Total Liabilities (2014 - 2025)

Arcadia Biosciences' Total Liabilities history runs 12 years deep, the most recent figure standing at $2.4 million for Q4 2025.

• Quarterly Total Liabilities fell 67.01% year-over-year to $2.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.4 million (down 67.01% YoY) and the FY2025 annual result came in at $2.4 million, down 67.01% from the prior year.
• Total Liabilities was $2.4 million for Q4 2025 at Arcadia Biosciences, down from $3.1 million in the prior quarter.
• Across five years, Total Liabilities topped out at $28.1 million in Q2 2021 and bottomed at $2.4 million in Q4 2025.
• A 5-year average of $9.7 million and a median of $8.0 million in 2022 frame the typical range for Total Liabilities.
• Annual changes were most pronounced in 2022 — Total Liabilities sank 70.7% — and 2023, when it soared 60.31%.
• Arcadia Biosciences' Total Liabilities stood at $12.7 million in 2021, then slumped by 36.94% to $8.0 million in 2022, then dropped by 12.72% to $7.0 million in 2023, then climbed by 4.17% to $7.3 million in 2024, then slumped by 67.01% to $2.4 million in 2025.
• Business Quant data shows RKDA's Total Liabilities at $2.4 million in Q4 2025, $3.1 million in Q3 2025, and $3.3 million in Q2 2025.